No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 48.1x · 10Y median 50.1x · 39th percentile · as of Oct 6, 2026
Annual revenue · last 5 fiscal years + TTM
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T21:58:22.029Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T21:58:22.029Z. Latest historical point 2025-12-31. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T21:58:22.029Z. Latest historical point 2025-12-31.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T21:58:22.029Z. Latest historical point 2025-12-31. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Strategy Inc (STRD) stock was $72.48 as of Oct 6, 2026, 4:00 PM EDT, down 1.59% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +1.0%
Strategy, Inc. engages in the provision of enterprise analytics and mobility software.
Software - Application · Tysons Corner, VA
Next Earnings Date
Nov 4, 2026
29 days away
EPS Estimate
13.29
Revenue Est.
$128.03M
Last Quarter Results
EPS
$-24.45
vs Estimate
$-2.19
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1STRD | $23.98B | $72.48 | -1.59% | +0.96% | N/A | N/A | N/A |
| 2IOT | $24.09B | $41.74 | -1.53% | +8.37% | N/A | N/A | vs STRD |
| 3FISV | $24.25B | $45.48 | -1.43% | -63.65% | -15.65% | -0.77% | vs STRD |
| 4STRK | $22.51B | $75.77 | -1.41% | -13.52% | N/A | N/A | vs STRD |
| 5ENTG | $25.45B | $166.89 | -0.02% | +67.10% | +7.17% | +25.87% | vs STRD |
| 6PTC | $22.29B | $193.00 | +0.38% | -5.27% | +9.91% | +15.41% | vs STRD |
$122.37M
vs Estimate
$122.99M
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$72.48
High
N/A
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $12.04 | $13.29 | $14.23 | 1 |
| Quarter ending Dec 2026 | $13.40 | $14.79 | $15.84 | 1 |
| Quarter ending Mar 2027 | $1.59 | $1.75 | $1.88 | 1 |
| Quarter ending Jun 2027 | $1.72 | $1.90 | $2.04 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-26.25 | $-24.25 | $-21.21 | 1 |
| FY 2027 | $12.65 | $14.45 | $15.65 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $120.75M | $128.03M | $135.30M | 10 |
| Quarter ending Dec 2026 | $117.29M | $126.41M | $133.31M | 10 |
| Quarter ending Mar 2027 | $119.71M | $129.02M | $136.06M | 9 |
| Quarter ending Jun 2027 | $117.83M | $127.00M | $133.93M | 9 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $462.15M | $500.78M | $531.08M | 13 |
| FY 2027 | $451.11M | $509.59M | $543.46M | 9 |
